- Home
- VVPR vs NRSN Comparison
VVPR vs NRSN Comparison
Compare VVPR & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVPR
- NRSN
- Stock Information
- Founded
- VVPR 2014
- NRSN 2017
- Country
- VVPR United Kingdom
- NRSN Israel
- Employees
- VVPR N/A
- NRSN N/A
- Industry
- VVPR Power Generation
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- VVPR Utilities
- NRSN Health Care
- Exchange
- VVPR Nasdaq
- NRSN Nasdaq
- Market Cap
- VVPR 27.0M
- NRSN 26.0M
- IPO Year
- VVPR 2016
- NRSN 2021
- Fundamental
- Price
- VVPR $2.80
- NRSN $0.99
- Analyst Decision
- VVPR
- NRSN Hold
- Analyst Count
- VVPR 0
- NRSN 1
- Target Price
- VVPR N/A
- NRSN N/A
- AVG Volume (30 Days)
- VVPR 10.6M
- NRSN 130.1K
- Earning Date
- VVPR 01-01-0001
- NRSN 04-07-2025
- Dividend Yield
- VVPR N/A
- NRSN N/A
- EPS Growth
- VVPR N/A
- NRSN N/A
- EPS
- VVPR N/A
- NRSN N/A
- Revenue
- VVPR $79,000.00
- NRSN N/A
- Revenue This Year
- VVPR N/A
- NRSN N/A
- Revenue Next Year
- VVPR N/A
- NRSN N/A
- P/E Ratio
- VVPR N/A
- NRSN N/A
- Revenue Growth
- VVPR N/A
- NRSN N/A
- 52 Week Low
- VVPR $0.62
- NRSN $0.51
- 52 Week High
- VVPR $6.66
- NRSN $1.50
- Technical
- Relative Strength Index (RSI)
- VVPR 52.46
- NRSN 44.13
- Support Level
- VVPR $2.35
- NRSN $0.97
- Resistance Level
- VVPR $2.90
- NRSN $1.04
- Average True Range (ATR)
- VVPR 0.49
- NRSN 0.09
- MACD
- VVPR -0.18
- NRSN 0.00
- Stochastic Oscillator
- VVPR 26.01
- NRSN 57.04
About VVPR VivoPower International PLC
Vivopower International PLC is a solar power company. It provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions, Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Electric Vehicles segment. Geographically its key revenue derives from the Netherlands.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.